Skip to content

Can BioGaia be used long-term? A Comprehensive Guide to Safety and Efficacy

5 min read

According to numerous clinical trials, the BioGaia probiotic strain, Limosilactobacillus reuteri DSM 17938, has an extensive safety record in both children and adults, even with daily and prolonged use. Can BioGaia be used long-term for sustained benefits?

Quick Summary

BioGaia, featuring the well-researched strain Limosilactobacillus reuteri, is generally considered safe for long-term, daily use in healthy individuals, including infants and children.

Key Points

  • Extensive Research: The BioGaia strain, L. reuteri DSM 17938, has been proven safe and well-tolerated in numerous clinical trials involving infants, children, and adults.

  • No Long-Term Adverse Effects: Long-term studies, including those lasting up to 12 months in infants, have identified no serious adverse effects in healthy populations.

  • Temporary Colonization: L. reuteri does not permanently colonize the gut, meaning continuous, daily intake is required to maintain its benefits.

  • Effective for Chronic Issues: Long-term use is effective for sustained relief from conditions like infantile colic, functional constipation, and antibiotic-associated diarrhea.

  • Risks for Vulnerable Groups: While safe for most, immunocompromised individuals or those with other severe conditions should use probiotics only under medical supervision due to rare infection risks.

  • Individual Response Varies: The effectiveness of probiotics can differ significantly between individuals based on their unique gut flora, diet, and lifestyle.

In This Article

The Foundation of BioGaia: Understanding Limosilactobacillus reuteri

BioGaia products are centered around the specific, patented probiotic strain Limosilactobacillus reuteri DSM 17938 (previously known as Lactobacillus reuteri). This strain was originally isolated from human breast milk and is a natural colonizer of the human gastrointestinal tract. Its probiotic effects are largely driven by its ability to produce reuterin, a broad-spectrum antimicrobial substance that helps inhibit the growth of harmful pathogens. This specific, human-adapted strain and its well-documented properties are what differentiate BioGaia products and form the basis for their use in managing a variety of gastrointestinal issues, from infantile colic and constipation to antibiotic-associated diarrhea.

Long-Term Safety: Evidence from Clinical Studies

Safety is a primary concern for any supplement used over an extended period. The good news is that BioGaia, and specifically the L. reuteri DSM 17938 strain, has been thoroughly studied, providing strong evidence for its long-term safety in healthy populations.

Here are some key findings from the research:

  • Infants and Children: Studies have shown that supplementation with L. reuteri DSM 17938 for 12 months in infants resulted in no clinical tolerance problems or severe adverse events, with growth indices and GI symptoms remaining similar to the placebo group. Further follow-up at seven years also revealed no long-term side effects. The drops are also documented as safe for infants from birth.
  • Adults: A placebo-controlled trial investigated the long-lasting administration of L. reuteri DSM 17938 over 105 days in adults with functional constipation, with beneficial effects noted and no safety concerns identified. BioGaia confirms its products are safe for long-term, daily consumption in adults.
  • High Dosages: Clinical trials testing doses far exceeding the normal recommended amount have also shown no serious adverse effects. BioGaia itself confirms that serious adverse effects are very rare, and typical, temporary GI side effects disappear after a few days.
  • Pregnancy and Breastfeeding: Several studies have confirmed the safety of consuming BioGaia products during pregnancy and breastfeeding.

Is It Necessary to Use BioGaia Continuously?

Because the L. reuteri strain does not permanently colonize the gut of modern humans, its presence and benefits are temporary. The effects typically diminish within a week or two after discontinuing use, necessitating regular intake to maintain a consistent beneficial supply of the bacteria. This is why BioGaia is often recommended for daily, long-term administration, especially for managing chronic issues like constipation or functional abdominal pain.

Efficacy Over Time for Specific Conditions

Research supports the long-term effectiveness of BioGaia for a number of specific health issues:

  • Infantile Colic: For breastfed infants with colic, numerous trials show that daily supplementation with L. reuteri DSM 17938 significantly reduces daily crying time. Long-term use can help maintain these benefits.
  • Functional Constipation: The strain has been shown to improve bowel movement frequency and symptoms of abdominal discomfort in both infants and adults with functional constipation, with benefits sustained during prolonged administration.
  • Antibiotic-Associated Diarrhea: A recent clinical trial showed that daily supplementation with BioGaia's probiotic strain significantly reduced the incidence of antibiotic-associated diarrhea in children. Long-term supplementation can be used to prevent such issues.
  • Oral Health: In addition to gut health, certain BioGaia products also benefit oral health. Long-term use of specific lozenges has been linked to a reduction in inflammation associated with gingivitis and a decrease in harmful oral bacteria.

Potential Risks and Individual Considerations

While generally safe, there are some important considerations for long-term probiotic use:

  • Initial Side Effects: Some individuals may experience mild, temporary gastrointestinal discomfort such as gas, bloating, or loose stools when they first start taking a probiotic. These symptoms typically subside within a few days as the gut adjusts.
  • Vulnerable Populations: For critically ill or immunocompromised patients, such as those undergoing chemotherapy, the risk of probiotic-related infections can increase. These individuals should only use probiotics under strict medical supervision.
  • Individual Variability: The efficacy and effects of probiotics can vary greatly from person to person depending on their unique gut microbiota, diet, lifestyle, and genetics. For optimal results, a personalized approach based on individual needs may be necessary.
  • Animal vs. Human Studies: Some animal studies using multi-strain probiotics (not BioGaia) have raised theoretical concerns about long-term use leading to a pro-inflammatory response or cardiovascular risk indicators. However, human clinical trials on the specific L. reuteri strains in BioGaia have not shown these adverse effects. The difference in the strain(s) used and study population is critical.

Short-Term vs. Long-Term BioGaia Use: A Comparison

Feature Short-Term Use (e.g., 1-4 weeks) Long-Term Use (e.g., 3+ months)
Typical Duration A few weeks, such as during or after a course of antibiotics or for initial colic relief. Daily, ongoing supplementation for chronic conditions or general gut health maintenance.
Primary Goal Targeted relief from acute symptoms like diarrhea or short-term digestive upset. Sustained management of chronic issues like constipation, functional abdominal pain, or long-term gut health support.
Expected Effects Rapid improvement in symptoms; for infants, crying time can decrease within weeks. Maintenance of benefits; continued improvement in bowel regularity and reduced discomfort.
Side Effects Mild, temporary gas or bloating may occur during the initial adjustment period. Minor, rare side effects in healthy individuals. Should be monitored in at-risk groups.
Monitoring Observe for initial symptomatic relief and tolerance. Regular check-ins with a healthcare professional, especially if managing a condition.
Dependency None. Benefits typically wane after cessation. None. Regular intake is required to sustain effects.

Conclusion

Based on decades of clinical research, BioGaia products containing the Limosilactobacillus reuteri DSM 17938 strain have a well-documented safety profile for long-term, daily use in healthy adults, children, and infants. For individuals with specific conditions like infant colic, functional constipation, or as a preventative measure for antibiotic-associated diarrhea, ongoing supplementation can be a safe and effective strategy to maintain benefits. While the strain does not permanently colonize the gut and requires continuous intake, its use is not associated with dependency. As with any long-term health regimen, especially for those with pre-existing health conditions, consultation with a healthcare professional is advisable to ensure it is the right and most effective approach for your individual needs. For more details on the strain and its applications, consult the official BioGaia website or medical research portals.

Note: For individuals with compromised immune systems or severe underlying health issues, expert medical guidance is critical before starting or continuing any long-term probiotic regimen.

How to Decide on Long-Term BioGaia Use

  • Identify Your Goals: Are you targeting a specific, chronic condition like functional constipation or managing infant colic? The purpose can help determine if continuous use is appropriate.
  • Monitor Effects: Pay attention to how your body or your child's body responds. If symptoms improve and benefits are sustained, continued use may be justified.
  • Listen to Your Body: Mild initial side effects are common, but if they persist or worsen, it may signal that the probiotic isn't the right fit for you.
  • Consult a Professional: A healthcare provider can offer personalized advice based on your health history, especially if you or your child have underlying medical conditions.
  • Prioritize a Healthy Diet: Remember that probiotics work best as part of a healthy, fiber-rich diet that supports a diverse microbiome naturally.

Ultimately, for healthy individuals, taking BioGaia for the long-term is well-supported by evidence and generally considered a safe way to maintain digestive and overall health.

Frequently Asked Questions

For healthy individuals, serious side effects from long-term BioGaia use are extremely rare. Some people may experience mild, temporary gastrointestinal symptoms like gas or bloating when first starting, but these typically resolve quickly as the gut adjusts.

Yes, extensive clinical research has shown BioGaia Protectis drops, which contain L. reuteri DSM 17938, to be safe and well-tolerated for long-term use in infants and children, with studies documenting safety for up to 12 months.

No, you do not become dependent on BioGaia. The probiotic strain does not permanently establish itself in the gut, so its beneficial effects are temporary and require consistent intake to be maintained. If you stop taking it, the introduced bacteria will eventually leave your system.

If you stop taking BioGaia, the population of L. reuteri in your gut will decrease. Any benefits you were experiencing, such as improved bowel motility or reduced colic symptoms, may gradually subside over a few weeks.

Long-term use is typically appropriate for managing chronic, functional gastrointestinal issues like constipation or for maintaining overall gut health. It is best to discuss your specific health needs and goals with a healthcare provider to determine if and for how long it is right for you.

BioGaia, like other probiotics, carries a theoretical risk of infection for individuals with severely compromised immune systems. Critically ill or immunocompromised individuals should always consult a doctor before using any probiotic.

Yes, several studies have confirmed that BioGaia's probiotic products can be safely consumed by pregnant and breastfeeding individuals.

References

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Medical Disclaimer

This content is for informational purposes only and should not replace professional medical advice.